US 12188017
Compositions and methods for inhibiting gene expression of alpha-1 antitrypsin
granted A61PA61P1/16A61P31/00
Quick answer
US patent 12188017 (Compositions and methods for inhibiting gene expression of alpha-1 antitrypsin) held by Arrowhead Pharmaceuticals, Inc. expires Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Arrowhead Pharmaceuticals, Inc.
- Grant date
- Tue Jan 07 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61P, A61P1/16, A61P31/00